±±¾©Ê¯ÓÍ»¯¹¤Ñ§Ôº2026ÄêÑо¿ÉúÕÐÉú½ÓÊÕµ÷¼Á¹«¸æ
²é¿´: 462  |  »Ø¸´: 0

springsunyj

ÖÁ×ðľ³æ (ÎÄѧ̩¶·)

[½»Á÷] 2011Äê¶È£¨NSFC£©¡ª¼ÓÄôóÎÀÉúÑо¿Ôº£¨CIHR£©½¡¿µÑо¿ºÏ×÷¼Æ»®ÏîÄ¿ÉêÇëÖ¸ÄÏ

2011Äê¶È¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á£¨NSFC£©¡ª¼ÓÄôóÎÀÉúÑо¿Ôº£¨CIHR£©½¡¿µÑо¿ºÏ×÷¼Æ»®ÏîÄ¿ÉêÇëÖ¸ÄÏ

--------------------------------------------------------------------------------

×÷Õß:κÇÛ¡¡¡¡¡¡·¢±íʱ¼ä:2011-01-19¡¡¡¡¡¡Õª×Ô:¹ú¼ÊºÏ×÷¾Ö



¡¡¡¡ÎªÍƶ¯ºÍÖ§³ÖÎÒ¹ú¿ÆÑ§¼ÒÔÚ¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðµÄ×ÊÖúÏÂÓë¼ÓÄôó¿ÆÑ§¼ÒÔÚÎÀÉúÁìÓòµÄ½»Á÷ÓëºÏ×÷£¬´Ù½øÖмÓÁ½¹ú´óѧ¡¢Ò½Ôº¡¢¿ÆÑÐÔºËù¼°Æä¸½Êô»ú¹¹¼ä¿ÆÑ§ºÏ×÷µÄ·¢Õ¹£¬¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á£¨NSFC£©Óë¼ÓÄôóÎÀÉúÑо¿Ôº£¨CIHR£©ÓÚ2005Äê12ÔÂÇ©Êð²¢ÓÚ2010Äê10ÔÂÐøÇ©Á˹ØÓÚ¿ªÕ¹½¡¿µÑо¿ºÏ×÷¼Æ»®µÄÁ½ⱸÍü¼¡£2006¡«2010Ä꣬˫·½Òѹ²Í¬×ÊÖú89¸öºÏ×÷Ñо¿ÏîÄ¿¡£

¡¡¡¡2011Ä꣬ÖмÓË«·½½«¼ÌÐøÕ÷¼¯×ÊÖú¸Ã½¡¿µÑо¿ºÏ×÷¼Æ»®ÏîÄ¿£¬¾ßÌå˵Ã÷ÓëÒªÇóÈçÏ£º

¡¡¡¡Ò»¡¢ÏîĿ˵Ã÷

¡¡¡¡£¨Ò»£©×ÊÖúÏîÄ¿Êý£º²»³¬¹ý15¸öÏîÄ¿£»

¡¡¡¡£¨¶þ£©ÏîĿִÐÐÆÚ£º3Ä꣨2012.1.1¡«2014.12.31£©£¬ÉêÇëÈËÐëÔÚÿÄêÄêÄ©Ìá½»ÏîÄ¿½øÕ¹±¨¸æ£¬ÏîĿִÐнáÊøºóÐëÌá½»½áÌⱨ¸æ¡£

¡¡¡¡£¨Èý£©×ÊÖúÇ¿¶È£ºÖз½×î¸ß¶î¶È£º100ÍòÈËÃñ±Ò/3Äꣻ¼Ó·½×î¸ß¶î¶È£º22.5Íò¼ÓÔª/3Äê¡£

¡¡¡¡£¨ËÄ£©×ÊÖúÁìÓò¼°Öз½ÏîÄ¿ÉêÇë´úÂ룺

¡¡¡¡1) Neurosciences: to provide support for basic research in neuroscience, mental health, addiction and the senses.£¨ÉêÇë´úÂ룺H09£©

¡¡¡¡2) Diabetes and Obesity: to provide support for research on the measures, causes, prevention, treatment and consequences of diabetes and obesity.£¨ÉêÇë´úÂ룺H07£©

¡¡¡¡3) Cardiovascular System: to provide support for basic and translational research on the pathogenesis, treatment and ultimate of cardiovascular diseases, including myocardial infarction, stroke, cardiomyopathy and atherosclerosis.£¨ÉêÇë´úÂ룺H02£©

¡¡¡¡4) Cancer: to provide support for basic research on cancer genetics and epigenetics and tumor metastasis.£¨ÉêÇë´úÂ룺H16£©

¡¡¡¡5) Infection and Immunity: to provide support for basic research on viral and bacterial diseases and development of vaccines.£¨ÉêÇë´úÂ룺H10£©

¡¡¡¡6) Child and Youth Health: to provide support for research on fertility, pregnancy, maternal health, healthy child development and the etiology, prevention, and treatment of diseases in infants, children, and youth.£¨ÉêÇë´úÂ룺H04£©

¡¡¡¡7) Aging, Gerontology and Geriatrics: to encourage research on aging processes, on functional limitations in older adults as a consequence of disease, and on determinants of healthy aging within the context of one or more of the following priority areas: healthy and successful aging, biological mechanisms of aging, cognitive impairment in aging, aging and maintenance of functional autonomy, and health services relating to older people.£¨ÉêÇë´úÂ룺H25£©

¡¡¡¡8) Gender and Health: to provide support for research on biological considerations in reproductive health.£¨ÉêÇë´úÂ룺H04£©

¡¡¡¡9) Musculoskeletal Health and Arthritis: to provide support on one or more of the three strategic priorities such as: physical activity, mobility and health; tissue injury, repair and replacement; pain, disability and chronic disease. £¨ÉêÇë´úÂ룺H06£©

¡¡¡¡10) Genetics: to provide support for research on the human and other genomes and on all aspects of genetic, basic biochemistry and cell biology related to health and disease.£¨Îª±ãÓÚÏîÄ¿¹ÜÀí£¬ËùÓÐÒÅ´«Ñ§ÁìÓòµÄÏîÄ¿ÉêÇëÑ¡ÔñÉêÇë´úÂ룺H16£©

¡¡¡¡ÉêÇëÈËÐëÑ¡ÔñÒÔÉÏÁÐÃ÷µÄÉêÇë´úÂëÌîдÉêÇëÊ飨ÀýÈ磬Éñ¾­¿ÆÑ§ÁìÓòÖ»Ìîд¡°H09¡±¼´¿É£¬ÎÞÐ迼ÂǾßÌåµÄÑо¿·½Ïò´úÂ룩£¬¶ÔÓÚδ°´ÒªÇóÌîдÒÔÉÏÖ¸¶¨ÉêÇë´úÂëµÄÉêÇëÊ飬½«²»ÓèÊÜÀí¡£

¡¡¡¡¶þ¡¢ÉêÇëÒªÇó

¡¡¡¡£¨Ò»£©Öз½ÉêÇëÈËÓ¦¾ßÓи߼¶×¨Òµ¼¼ÊõÖ°Îñ£¨Ö°³Æ£©£»Ó¦ÊÇÕýÔڳе£»ò³Ðµ£¹ý3ÄêÆÚÒÔÉϹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿µÄ¸ºÔðÈË£¨ÔÚ¶Á²©Ê¿¼°²©Ê¿ºó¿ÉÒԲμÓÏîÄ¿Ñо¿£¬µ«²»µÃ×÷ΪÏîÄ¿µÄÉêÇëÈË£©¡£

¡¡¡¡£¨¶þ£©ºÏ×÷Ñо¿Ó¦Ö÷ÒªÎ§ÈÆÌØ¶¨¿ÆÑ§ÎÊÌ⣻ּÔÚ¸ÄÉÆÈËÃñ½¡¿µÓëÉú»îÖÊÁ¿£»ÉêÇëÈËÓ¦Äܹ»³É¹¦ÊµÊ©ºÏ×÷Ñо¿£»³ä·Ö·¢»ÓºÏ×÷Ë«·½µÄ֪ʶר³¤£»Ôö½ø¿çѧ¿Æ¼äºÏ×÷£»¹ÄÀøÇàÄê¿ÆÑÐÈËÔ±²ÎÓë¡£

¡¡¡¡£¨Èý£©Öз½ÉêÇëÈËÓ¦°´ÕÕ±¾ÏîÄ¿ÉêÇëÖ¸ÄϵÄÒªÇóÏòÎÒίÌá½»ÉêÇ룻¼Ó·½ºÏ×÷ÕßÓ¦°´ÕÕCIHR¹«²¼µÄÏîÄ¿ÉêÇëÖ¸ÄϵÄÒªÇóÏòCIHRÌá½»ÉêÇë¡£¶ÔÓÚµ¥·½Ìá½»µÄÉêÇ룬½«²»ÓèÊÜÀí¡£

¡¡¡¡Èý¡¢ÏÞÏî¹æ¶¨

¡¡¡¡±¾ÏîÄ¿ÊôÓÚ¹ú¼Ê£¨µØÇø£©ºÏ×÷Ñо¿ÏîÄ¿£¬Ðë×ñÑ­ÒÔÏÂÏÞÏî¹æ¶¨£º

¡¡¡¡£¨Ò»£©ÉêÇëÈË£¨²»º¬²ÎÓëÕߣ©Í¬ÄêÖ»ÄÜÉêÇë1Ïî¹ú¼Ê£¨µØÇø£©ºÏ×÷Ñо¿ÏîÄ¿£»

¡¡¡¡£¨¶þ£©±¾ÏîÄ¿¼ÆÈë¾ßÓи߼¶×¨Òµ¼¼ÊõÖ°Îñ£¨Ö°³Æ£©µÄÈËÔ±ÉêÇ루°üÀ¨ÉêÇëÈ˺ÍÖ÷Òª²ÎÓëÕߣ©ºÍ³Ðµ££¨°üÀ¨¸ºÔðÈ˺ÍÖ÷Òª²ÎÓëÕߣ©ÏîÄ¿×ÜÊýÏÞ3ÏîµÄ·¶Î§£»

¡¡¡¡¹ØÓÚÏÞÏî¹æ¶¨µÄÏêϸ˵Ã÷£¬Çë¼û¡¶2011Äê¶È¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîĿָÄÏ¡·¡£

¡¡¡¡ËÄ¡¢É걨˵Ã÷

¡¡¡¡£¨Ò»£©Öз½ÉêÇëÈËÐëµÇ¼ISIS¿ÆÑ§»ù½ðÍøÂçϵͳ£¨http://isis.nsfc.gov.cn£©£¬ÔÚÏßÌ¡¶¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ð¹ú¼Ê£¨µØÇø£©ºÏ×÷Óë½»Á÷ÏîÄ¿ÉêÇëÊé¡·(ÒÔϼò³Æ¡°ÖÐÎÄÉêÇëÊ顱)¡£¾ßÌå²½ÖèÊÇ£ºÑ¡Ôñ¡°ÏîÄ¿¸ºÔðÈË¡±Óû§×éµÇ¼ϵͳ£¬½øÈëºóµã»÷¡°¹ú¼ÊºÏ×÷ÏîÄ¿ÉêÇ롱һÀ¸Öеġ°ÉêÇë¹ú¼ÊºÏ×÷ÀàÏîÄ¿¡±£¬ÔÙµã»÷¡°ÌîдÉêÇëÊ顱°´Å¥£¬ÔÚÏîÄ¿ÀàÐÍÖÐÑ¡Ôñ¡°ºÏ×÷Ñо¿¡±£¬µã»÷Õ¹¿ª×ÓÀà±ðºó£¬Ñ¡ÔñÏîÄ¿Ãû³Æ¡°NSFC-CIHRÏîÄ¿£¨Öмӣ©¡±£¬Çë°´ÕÕϵͳÌáʾÌîÈëÒ»¸öÉêÇëÈËÔø¾­Ö÷³Ö¹ý»òÕýÔÚÖ÷³ÖµÄÈýÄêÆÚ£¨º¬£©ÒÔÉϹú¼Ò×ÔÈ»¿ÆÑ§»ù½ðÏîÄ¿±àºÅ£¬Í¨¹ýϵͳÉóºËÖ®ºó£¬¼´¿É½øÈëÉêÇëÊéÌîд½çÃæ£¬ÔÚÏßÌîд²¢Ìá½»ÉêÇëÊé¡£ÖÐÎÄÉêÇëÊéÓ¦ÓëÓ¢ÎÄÉêÇëÊéµÄÄÚÈÝÒ»Ö¡£

¡¡¡¡£¨¶þ£©ÉêÇëÈ˳ýÁËÌîдÌá½»ÖÐÎÄÉêÇëÊéÒÔÍ⣬ÐëÒÔ¸½¼þµÄÐÎʽÉÏ´«ÒÔÏÂÉ걨²ÄÁÏ£º

¡¡¡¡1¡¢Ó¢ÎÄÉêÇëÊ飨CHINA-CANADA Joint Health Research Initiative Proposal£©£ºÖз½ÉêÇëÈËÇëÔÚ±¾ÏîÄ¿Õ÷¼¯Ö¸Äϸ½¼þ²¿·ÖÏÂÔØÓ¢ÎÄÉêÇëÊ飬²¢Ñϸñ°´ÕÕÓ¢ÎÄÉêÇëÊé¸÷°æ¿é¾ßÌåµÄÒªÇó£¨ÈçÆª·ùÏÞÖÆ£©ÌîдӢÎÄÉêÇëÊ飬ÆäÖС°B2. Project Description¡±°æ¿éµÄÄÚÈݲ»Äܳ¬¹ý5Ò³¡£Ë«·½ÉêÇëÈËÌá½»µÄÓ¢ÎÄÉêÇëÊéÄÚÈÝÓ¦ÍêȫһÖ£¬¸ÃÏîÄ¿µÄͬÐÐÆÀÒ齫ÒÔ´ËÓ¢ÎÄÉêÇëÊéÄÚÈÝΪ׼¡£

¡¡¡¡2¡¢¼Ó·½ºÏ×÷ÕßÏòCIHRÌá½»µÄÈ«Ì×Ó¢ÎÄÉêÇë²ÄÁÏ£¨Research Module¡¢Operating Budget ModuleºÍCommon CV°æ¿éÄÚÈÝ£©£¬Óɼӷ½ºÏ×÷ÕßÌîдÍê±Ïºó½«µç×Ó°æÌṩ¸øÖз½ÉêÇëÈË£¬²¢×÷ΪÖÐÎÄÉêÇëÊéµÄ¸½¼þÔÚISISϵͳÖÐÉÏ´«¡£

¡¡¡¡3¡¢¼Ó·½ÉêÇëÈËÇ©ÊðµÄºÏ×÷È·ÈϺ¯£¨ºÏ×÷È·ÈϺ¯ÖÐÓ¦¶Ô´ËÏîÄ¿µÄÃû³Æ¡¢ºÏ×÷µ¥Î»¼°ÈËÔ±ÐÅÏ¢ÓèÒÔÃ÷ȷ˵Ã÷£©¡£

¡¡¡¡£¨Èý£©ÔÚÏßÌîдÌá½»Íê±Ïºó£¬»¹Ðè´òÓ¡Ò»Ì×ISISϵͳÉú³ÉµÄ´øÓпÆÑ§²¿ÊÜÀíºÅµÄÖ½ÖÊÖÐÎÄÉêÇëÊ飬ǩ×Ö²¢¼Ó¸ÇÒÀÍе¥Î»¹«Õºó£¬Á¬Í¬±¾²¿·ÖµÚ£¨¶þ£©ÌõËùÁÐÉ걨²ÄÁÏÒ»²¢±¨Ë͹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðί¹ú¼ÊºÏ×÷¾ÖÃÀ´ó¼°¶«Å·´¦¡£

¡¡¡¡Ö½ÖÊÉêÇë²ÄÁÏÐëÓëISISϵͳÖÐÌá½»µÄµç×Ó°æÉêÇë²ÄÁÏÍêȫһÖ¡£

¡¡¡¡Îå¡¢ÏîÄ¿ÊÜÀí½ØÖ¹ÈÕÆÚ£º2011Äê3ÔÂ18ÈÕ£¨Ö½ÖÊÉêÇëÊéÒÔÓÊ´ÁΪ׼£©¡£

¡¡¡¡×¢£ºÇëÉêÇëÈËÑϸñ×ñÕÕ±¾ÏîĿָÄϵĸ÷ÏîÒªÇóÌÉêÇ룬²»·ûºÏÉÏÊöÒªÇóµÄÉêÇ뽫ÎÞ·¨½øÈëÉóÅú³ÌÐò£¬ÊÓΪÎÞЧÉêÇë¡£¼Ó·½ÉêÇëÈËÇëµÇ¼¼ÓÄôóÎÀÉúÑо¿Ôº£¨CIHR£©ÍøÕ¾°ìÀíÏîÄ¿ÉêÇëÊÖÐø¡£

¡¡¡¡Áù¡¢ÁªÏµ·½Ê½£º

¡¡¡¡£¨Ò»£©ÏîÄ¿ÉêÇëÊÂÒË£º

¡¡¡¡µØ¡¡Ö·£º±±¾©Êк£µíÇøË«Çå·83ºÅ

¡¡¡¡¡¡¡¡¡¡¡¡¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðίԱ»á¹ú¼ÊºÏ×÷¾ÖÃÀ´ó¼°¶«Å·´¦

¡¡¡¡ÓÊ¡¡±à£º100085

¡¡¡¡ÁªÏµÈË£ºÎºÇÛ  ³Â»´

¡¡¡¡µç¡¡»°£º010-62325544£»010-62327017

¡¡¡¡´«¡¡Õ棺010-62327004

¡¡¡¡µç¡¡ÓÊ£ºweiqin@nsfc.gov.cn£»chenhuai@nsfc.gov.cn

¡¡¡¡£¨¶þ£©Öз½ÉêÇëÈËÔÚÏßÌîдÉêÇëÊé¹ý³ÌÖÐÈçÓм¼ÊõÎÊÌ⣬¿ÉÁªÏµÎÒίISISϵͳ¼¼ÊõÖ§³Ö

¡¡¡¡µç¡¡»°£º010-62317474

¡¡¡¡£¨Èý£©¼Ó·½ÉêÇëÈËÇëÓëCIHRÁªÏµ£¬ÁªÏµ·½Ê½ÈçÏ£º

¡¡¡¡1. For questions about this initiative and research objectives contact:

¡¡¡¡Dr. Elizabeth Th¨¦riault

¡¡¡¡Assistant Scientific Director

¡¡¡¡CIHR¡¯s Institute of Neurosciences, Mental Health and Addiction

¡¡¡¡Strangway Building

¡¡¡¡University of British Columbia

¡¡¡¡430 - 5950 University Blvd.

¡¡¡¡Vancouver, BC V6T 1Z3

¡¡¡¡Telephone: +1-604-827-4744

¡¡¡¡Fax: +1-604 827-3373

¡¡¡¡Email: elizabeth.Theriault@ubc.ca

¡¡¡¡2. For questions on CIHR funding guidelines, how to apply, and the peer review process contact:

¡¡¡¡Dr. Christine Francoeur

¡¡¡¡Program Delivery Coordinator

¡¡¡¡Canadian Institutes of Health Research

¡¡¡¡Telephone: +1-613-952-4256

¡¡¡¡Fax: +1-613-954-1800

¡¡¡¡Email: christine.francoeur@cihr-irsc.gc.ca

¡¡¡¡¸½¼þ£ºÓ¢ÎÄÉêÇëÊ飨CHINA-CANADA Joint Health Research Initiative Proposal£©



Á´½ÓµØÖ·£ºhttp://www.nsfc.gov.cn/Portal0/InfoModule_396/31601.htm
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

» ±¾Ö÷ÌâÏà¹ØÉ̼ÒÍÆ¼ö: (ÎÒÒ²ÒªÔÚÕâÀïÍÆ¹ã)

ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
Ïà¹Ø°æ¿éÌø×ª ÎÒÒª¶©ÔÄÂ¥Ö÷ springsunyj µÄÖ÷Ìâ¸üÐÂ
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 308Çóµ÷¼Á +13 ÌÈÈôÆð·çÁËÄØ 2026-04-05 13/650 2026-04-06 14:20 by ½¯ð©Óí
[¿¼ÑÐ] 324Çóµ÷¼Á +3 k¿ÉÀÖ 2026-04-05 4/200 2026-04-06 09:54 by À¶ÔÆË¼Óê
[¿¼ÑÐ] 301Çóµ÷¼Á +6 ϸ°ûÏà¹Øµ°°× 2026-04-02 10/500 2026-04-06 08:34 by jp9609
[¿¼ÑÐ] Çóµ÷¼Á +7 ÕÅ.1 2026-04-05 7/350 2026-04-05 20:40 by à£à£à£0119
[¿¼ÑÐ] 0854µç×ÓÐÅÏ¢319Çóµ÷¼Á£¨½ÓÊÜ¿çרҵµ÷¼Á£© +3 ÐÇÐDz»Õ£ÑÛà¶ 2026-04-05 3/150 2026-04-05 20:20 by à£à£à£0119
[¿¼ÑÐ] 315Çóµ÷¼Á +5 £¦123456789 2026-04-05 5/250 2026-04-05 19:55 by nepu_uu
[¿¼ÑÐ] 322Çóµ÷¼Á +3 àźߺߺã 2026-04-05 3/150 2026-04-05 19:52 by nepu_uu
[¿¼ÑÐ] µç×ÓÐÅÏ¢µ÷¼Á½»²æÑ§¿ÆÓÐÍÆ¼öÂð +6 jhtfeybgj 2026-04-01 9/450 2026-04-05 11:13 by Öí»á·É
[¿¼ÑÐ] ²ÄÁÏ»¯¹¤306·ÖÕÒºÏÊʵ÷¼Á +14 ²×º£ÇáÖÛe 2026-04-04 14/700 2026-04-05 09:53 by ÖìÔÆ»¢202
[¿¼ÑÐ] ר˶310Çóµ÷¼Á +5 ÀÌÀÌÎÒ¡­. 2026-04-04 6/300 2026-04-04 23:33 by barlinike
[¿¼ÑÐ] 283·ÖÇóµ÷¼Á +7 СÄô°®Ñ§Ï° 2026-04-03 7/350 2026-04-04 21:51 by hemengdong
[¿¼ÑÐ] Çóµ÷¼Á£º085600²ÄÁÏÓ뻯¹¤£¬¿¼²Ä¿Æ»ù£¬×Ü·Ö319 +21 678lucky 2026-03-31 26/1300 2026-04-04 16:22 by dongzh2009
[¿¼ÑÐ] 311Çóµ÷¼Á +11 Ó¸ҵÄСÎâ 2026-04-02 11/550 2026-04-03 21:46 by qlm5820
[¿¼ÑÐ] ¹¤¿Æ341·Öµ÷¼Á +3 Âå¶àÂÞ 2026-04-03 3/150 2026-04-03 14:20 by 1753564080
[¿¼ÑÐ] ÖØÇì´óѧ²ÄÁÏÓ뻯¹¤085600£¬³õÊÔ370+£¬ÇóÇóµ÷¼Á½¨Òé +8 shzhou_ 2026-04-01 9/450 2026-04-03 09:31 by À¶ÔÆË¼Óê
[¿¼ÑÐ] Ò»Ö¾Ô¸aÇø211£¬085601-307·ÖÇóµ÷¼Á +13 µ³¼ÎºÀ 2026-03-31 26/1300 2026-04-03 08:33 by 495374996
[¿¼²©] É격ÇóÖú +3 Reee1Llll 2026-04-01 3/150 2026-04-02 22:29 by ÕâÊÇÒ»¸öÎÞÁĵÄê
[¿¼ÑÐ] ²ÄÁÏ340·Öµ÷¼Á +7 ÏÄÒ¹Íí·ç_long 2026-04-02 9/450 2026-04-02 21:20 by dongzh2009
[¿¼ÑÐ] 272Çóµ÷¼Á£¬½ÓÊÜ¿çרҵµ÷¼Á£¡ +4 ÏÐÓ㬠2026-03-31 4/200 2026-04-02 11:18 by guyan1000
[¿¼ÑÐ] ¡¾Çóµ÷¼Á¡¿ÐÂÄÜÔ´²ÄÁϱ¾¿Æ£¬Ò»Ö¾Ô¸211£¬³õÊÔ321 +6 Çóµ÷¼ÁѧУ£¬ 2026-04-02 6/300 2026-04-02 09:41 by Çç¿Õ210210
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û